CLINIQUE skin supplies for men
Dosage form: lotion
Ingredients: octinoxate 7.4mL in 100mL, octisalate 5mL in 100mL, avobenzone 3mL in 100mL, oxybenzone 2mL in 100mL
Labeler: CLINIQUE LABORATORIES INC.
NDC Code: 49527-886
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
CLINIQUE
skin supplies
for men
WARNING
Keep out of eyes.
Stop use if irritation occurs. If irritation persists, consult a health care practitioner.
ACTIVE INGREDIENTS
OCTINOXATE 7.40% • OCTISALATE 5.00% • AVOBENZONE 3.00% • OXYBENZONE 2.00%
INGREDIENTS
WATER • BUTYLENE GLYCOL • DIMETHICONE • NEOPENTYL GLYCOL DIHEPTANOATE • CETEARYL ALCOHOL • SILICA • PEG-100 STEARATE • LACTOBACILLUS FERMENT • HORDEUM VULGARE (BARLEY) EXTRACT • ALGAE EXTRACT • CUCUMIS SATIVUS (CUCUMBER) FRUIT EXTRACT • HELIANTHUS ANNUUS (SUNFLOWER) SEEDCAKE • CHOLESTEROL • CETEARYL GLUCOSIDE • PROPYLENE GLYCOL DICAPRATE • CHAMOMILLA RECUTITA (MATRICARIA) • TRIDECYL TRIMELLITATE • HYDROGENATED LECITHIN • STEARYL ALCOHOL • ZEOLITE • TRIDECYL STEARATE • ISODODECANE • DIPENTAERYTHRITYL HEXACAPRYLATE/HEXACAPRATE • PVP • OLETH-10 • LAURETH-4 • LAURETH-23 • CAPRYLYL GLYCOL • HEXYLENE GLYCOL • POLYETHYLENE • TROMETHAMINE • CARBOMER • SODIUM CITRATE • DISODIUM EDTA • SODIUM BENZOATE • POTASSIUM SORBATE • CHLORPHENESIN • PHENOXYETHANOL • YELLOW 5 (CI 19140) • YELLOW 6 (CI 15985) • RED 33 (CI 17200) [ILN29625]
© CLINIQUE LABS., DIST.
NEW YORK,N.Y. 10022
PRINCIPAL DISPLAY PANEL - 100 ml Bottle Carton
CLINIQUE
skin supplies
for men
M protect
SPF 21
daily hydration + protection
ALL SKIN TYPES
3.4 FL.OZ.LIQ./100 ml e
CLINIQUE
SKIN SUPPLIES FOR MEN
octinoxate, octisalate, avobenzone, and oxybenzone lotion |
|
|
|
|
|
|
|
|
|
|
|
|
CLINIQUE LABORATORIES INC.
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
